Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, printing, and textile industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 72 Cr
P/E โ
Div Yield 0.43 %
Book Value โน221.00
52w High โน333.00
52w Low โน190.00
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
79.76
71.77
63.43
78.87
75.65
71.20
63.66
70.17
80.82
82.68
61.67
79.74
57.48
Expenses
78.87
73.01
64.08
79.23
75.52
71.07
59.48
66.80
78.24
81.32
61.56
79.51
56.71
Operating Profit
0.89
-1.24
-0.65
-0.36
0.13
0.13
4.18
3.37
2.58
1.36
0.11
0.23
0.77
OPM %
1.12
-1.73
-1.02
-0.46
0.17
0.18
6.57
4.80
3.19
1.64
0.18
0.29
1.34
Other Income
0.99
-0.31
0.40
0.05
0.69
-0.11
0.00
0.49
0.59
0.30
0.42
0.30
0.36
Depreciation
0.19
0.19
0.19
0.18
0.17
0.16
0.17
0.17
0.16
0.16
0.16
0.16
0.16
Interest
0.11
0.14
0.13
0.26
0.44
0.22
0.10
0.17
0.19
0.11
0.23
0.13
0.22
Profit before tax
1.58
-1.88
-0.57
-0.75
0.21
-0.36
3.91
3.52
2.82
1.39
0.14
0.24
0.75
Tax %
44.94
8.51
-19.30
-21.33
209.52
11.11
28.90
24.43
26.60
0.00
-142.86
175.00
18.67
Net Profit
0.88
-2.04
-0.46
-0.59
-0.23
-0.40
2.78
2.66
2.07
1.40
0.34
-0.19
0.61
EPS in Rs
2.85
-6.60
-1.49
-1.91
-0.74
-1.29
9.00
8.61
6.70
4.53
1.10
-0.61
1.97
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
290.00 286.00 282.00 311.00 222.00 179.00 137.00 111.00 93.00 73.00 63.00 47.00
Expenses
292.00 276.00 279.00 287.00 197.00 170.00 131.00 108.00 87.00 69.00 62.00 46.00
Operating Profit
-2.00 10.00 2.00 24.00 24.00 9.00 7.00 3.00 6.00 4.00 1.00 1.00
OPM %
-0.70 3.60 0.90 8.00 11.00 4.80 4.80 2.90 6.00 5.00 1.90 2.50
Other Income
1.00 1.00 1.00 0.00 1.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00
Interest
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Depreciation
1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax
-3.00 10.00 3.00 23.00 24.00 7.00 6.00 2.00 5.00 3.00 0.00 0.00
Tax %
11.00 28.00 14.00 26.00 27.00 27.00 27.00 29.00 35.00 37.00 33.00 35.00
Net Profit
-3.00 7.00 2.00 17.00 17.00 5.00 4.00 2.00 3.00 2.00 0.00 0.00
EPS in Rs
-10.71 23.01 6.99 53.82 55.60 17.25 13.72 4.98 10.42 5.66 0.97 1.04
Dividend Payout %
0.00 4.00 14.00 2.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00
Reserves
65.00 69.00 62.00 60.00 44.00 27.00 21.00 17.00 15.00 12.00 11.00 10.00
Borrowings
11.00 10.00 8.00 19.00 8.00 9.00 9.00 7.00 9.00 7.00 6.00 3.00
Other Liabilities
46.00 40.00 48.00 35.00 30.00 19.00 25.00 14.00 13.00 14.00 17.00 10.00
Total Liabilities
124.00 122.00 122.00 117.00 85.00 57.00 58.00 40.00 41.00 36.00 36.00 26.00
Fixed Assets
12.00 10.00 11.00 11.00 10.00 9.00 7.00 7.00 7.00 7.00 7.00 7.00
CWIP
1.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00
Investments
4.00 4.00 3.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 2.00 0.00
Other Assets
108.00 107.00 108.00 104.00 75.00 48.00 50.00 33.00 34.00 29.00 27.00 19.00
Total Assets
124.00 122.00 122.00 117.00 85.00 57.00 58.00 40.00 41.00 36.00 36.00 26.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
9.00 -10.00 9.00 -9.00 17.00 5.00 -1.00 2.00 0.00 -3.00 0.00 -1.00
Cash from Investing Activity
-3.00 0.00 0.00 -3.00 -1.00 -3.00 -2.00 2.00 -2.00 1.00 -2.00 0.00
Cash from Financing Activity
0.00 0.00 -11.00 10.00 -2.00 -2.00 2.00 -4.00 2.00 1.00 2.00 0.00
Net Cash Flow
6.00 -10.00 -2.00 -3.00 14.00 0.00 -1.00 1.00 -1.00 -1.00 0.00 0.00
Free Cash Flow
6.00 -11.00 9.00 -11.00 16.00 3.00 -3.00 2.00 0.00 -4.00 -1.00 -1.00
CFO/OP %
-493.00 -84.00 503.00 0.00 78.00 81.00 -7.00 126.00 17.00 -73.00 -25.00 -29.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
64.00 72.00 90.00 61.00 72.00 67.00 74.00 69.00 86.00 59.00 93.00 74.00
Inventory Days
56.00 52.00 28.00 43.00 24.00 25.00 55.00 28.00 31.00 41.00 37.00 38.00
Days Payable
55.00 53.00 65.00 42.00 45.00 39.00 67.00 45.00 46.00 43.00 104.00 76.00
Cash Conversion Cycle
65.00 71.00 53.00 62.00 51.00 53.00 61.00 52.00 70.00 58.00 26.00 36.00
Working Capital Days
52.00 68.00 47.00 40.00 32.00 36.00 39.00 37.00 32.00 34.00 14.00 19.00
ROCE %
-3.00 13.00 3.00 35.00 52.00 24.00 22.00 12.00 23.00 16.00 5.00 7.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
49.09
49.09
49.09
49.09
49.09
49.09
49.09
48.95
48.64
48.64
48.64
48.64
FIIs
3.24
3.24
3.24
3.24
0.00
3.24
3.24
3.24
3.24
3.24
3.24
3.24
DIIs
0.00
0.00
0.00
0.00
3.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Public
47.66
47.67
47.67
47.67
47.67
47.67
47.66
47.81
48.13
48.13
48.13
48.13
No. of Shareholders
6,330
6,311
6,488
6,699
6,752
6,785
6,844
6,984
7,169
7,478
8,065
8,445
Corporate Actions
4 records
Back to all stocks